SSO/KBCS Joint Virtual Tumor Board: Selective Omission of Sentinel Lymph Node Biopsy in cN0 Patients

Activity Overview

This event was held on Saturday, December 3 at 8:00AM (GMT) in Korea -- Friday, December 2 at 5:00PM (CST) in the United States.

This one-hour webinar will open with discussions of the US-based Choosing Wisely Guideline and the NAUTILUS study based in Korea and how each are managed in their respective countries regarding omitting sentinel lymph node biopsy in cN0 patients. Two cases will be presented which will highlight the differences and perhaps similarities of management of this process. Please view for what we hope will be a lively debate between experts of the two sponsoring organizations.

Moderators:

Jeong Eon Lee, MD, PhD, FACS, (Chairman, International Affairs Committee of KBCS) - Samsung Medical Center, Seoul, Korea

Christine Laronga, MD, FACS (Chair, Breast Disease Site Work Group of SSO) - Moffitt Cancer Center, Orlando, Florida, USA

Panelists:

Han-Byoel Lee, MD, PhD (KBCS) - Seoul National University Hospital, Seoul, Korea

Kelly Hunt, MD, FSSO (President-Elect, SSO) - University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Jung Eun Choi, MD, PhD (KBCS) - Yeungnam University Medical Center, Daegu, Korea

Judy Boughey, MD (SSO) - Mayo Clinic, Rochester, Minnesota, USA

Jai Min Ryu, MD, PhD (KBCS) - Samsung Medical Center, Seoul, Korea

Eun Young Kim MD, PhD (KBCS) - Kangbuk Samsung Hospital, Seoul, Korea

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered